European Glaucoma Society Foundation

Tweet this page
<
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 23 Oct 2023
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 05697037283-66 057343026395-60

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.1 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    European Glaucoma Society Foundation   (EGS)

    EU Transparency Register

    720911016370-40 First registered on 27 Mar 2015

    Goals / Remit

    To promote the best possible well being and minimal glaucoma-induced visual disability in individuals with glaucoma within an affordable healthcare system;

    To establish a network of glaucoma specialists at European and global level;

    To enhance knowledge exchange amongst glaucoma specialists and disseminate specific knowledge to the general ophthalmologists in Europe

    Main EU files targeted

    European Open Science Cloud
    Trustworthy Artificial Intelligence (guidelines; High-level expert group on artificial intelligence)
    Chronic non communicable diseases
    Joint Programming;
    Driving Licence Directive;
    Legislation on substances of human origin (blood, tissues, cells and organs);
    Data strategy;
    EMA and related files (pharmaceutical strategy; big data in medicine evaluation, biosimilars, repurposing of medicines);
    Revised Disability strategy;
    Cross border access to therapies.
    Metrology

    Address

    Head Office
    Zeughausgasse, 18
    ZUG Zug 6301 - 1225
    SWITZERLAND
    EU Office
    Zeughausgasse, 18
    ZUG Zug 6301 - 1225
    SWITZERLAND

    Website

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    10%1

    Lobbyists (Full time equivalent)

    0.1

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    The EGS draws on the expertise of its members on an ad hoc basis for activities such as briefing sessions with various DGs or input to consultations. This amounts to a cumulative time of less than 10% of a full-time job.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    World Glaucoma Association (WGA), a global Glaucoma Network; http://www.worldglaucoma.org/

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    460,000€

    Major funding types in closed year

    Other

    Funding types "other" information

    Major contributions in closed year

    None declared

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    Disability#Artificial intelligence and digital#Disability Intergroup European Parliament
    EU Parliament Interest Group on Rheumatic and Musculoskeletal Diseases

    Communication activities

    Futurium
    Consultations and hearings of the Expert Panel on Investment in Health;
    Digitalisation of healthcare;
    ERA-net (NEURON);
    ERNs (ERN-EYE);
    Horizon Europe and missions;
    EIP Active and Healthy Ageing and its evolution past 2020;
    Health research: priorities, improving effectiveness
    GDPR and health data;
    EU Public Health Policies 2020 and beyond;
    Pharmaceutical strategy;
    Legislative revision on substances of human origin (blood, tissues and cells)

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard